ArticleAnnals of translational medicine2025
Polyglactin mesh in preventing recurrent pneumothorax in primary spontaneous pneumothorax: a retrospective efficacy study.
Article in Annals of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: At present, surgical bullectomy together with pleurodesis has the highest efficacy in terms of preventing the recurrence of primary spontaneous pneumothorax (PSP). There is still debate in the type of pleurodesis. In this study, we aim to investigate the efficacy of polyglactin mesh covering comparing to the standard surgical pleurodesis. Methods: This is a retrospective study collecting PSP patients who underwent bullectomy with pleurodesis between January 2016 and August 2023. The patients were divided into two groups as mesh and non-mesh group. Propensity score-matching analysis (1:1) was performed to balance the patient characteristics. The primary outcome was the pneumothorax recurrence after the index operation analyzed by Kaplan-Meier method. Operative and post-operative results were compared using Chi-squared test, Student's Results: There are 151 PSP patients during the study period, 84 and 67 of them were in mesh and non-mesh group respectively. After propensity matched, there were 49 patients in each group. From the Kaplan-Meier analysis with the longest follow-up time as 48 months, as the non-inferiority trial, there was no statistically significant between two groups (P=0.23). Importantly, the mesh group showed lower operative time for 15 minutes (P=0.01), lower blood loss for 10 mL (P<0.001), and shorter duration of chest tube for 1 day (P=0.002). Conclusions: In PSP patients undergoing lung bullectomy with pleurodesis, using of polyglactin mesh coverage the entire lung facilitates less operative time, less intra-operative blood loss and shorter both length of stay and chest tube duration. Polyglactin mesh should be considered as an alternative option for surgical pleurodesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.